Infant Respiratory Distress Syndrome

The syndrome known as infantile respiratory distress syndrome (IRDS), also called respiratory distress syndrome of the newborn (RDSN), infantile surfactant deficiency disorder (SDD) [2], or hyaline membrane disease (HMD), affects premature infants due to lung structural immaturity and pulmonary surfactant production insufficiency during development. It may also occur from a neonatal infection or a genetic issue with the generation of proteins related to surfactants. The symptoms of IRDS start soon after delivery and include quick respiration (over 60 breaths per minute), a rapid heartbeat, retractions of the chest wall, grunting on expiration, flared nostrils, and blue staining of the skin. Premature infants die mainly because of respiratory distress syndrome (IRDS). To regulate blood sugar, blood salts, and blood pressure, intravenous fluids are given together with oxygen and a modest quantity of continuous positive airway pressure (CPAP). The use of CPAP for premature newborns...